Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease
Open Access
- 18 February 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (4) , 1743
Abstract
Cardiovascular disease remains a leading cause of global mortality, with many unresolved issues in current clinical treatment strategies despite years of extensive research. Due to the great progress in nanotechnology and gene therapy in recent years, the emerging gene therapy based on nanocarriers has provided a promising therapeutic alternative for cardiovascular diseases. This review outlines the status of nanocarriers as vectors in gene therapy for cardiovascular diseases, including coronary heart disease, pulmonary hypertension, hypertension, and valvular heart disease. It discusses challenges and future prospects, aiming to support emerging clinical treatments. This review is the first to summarize gene therapy using nanocarriers for valvular heart disease, highlighting their potential in targeting challenging tissues.Keywords
Funding Information
- National Natural Science Foundation of China (U23A20395, 82170375, 82202310, 11902211, 2023NSFSC1339, 2023NSFSC1630, ZYGD23021, 23HXFH009)
- Nature Science Foundation of Sichuan Province (U23A20395, 82170375, 82202310, 11902211, 2023NSFSC1339, 2023NSFSC1630, ZYGD23021, 23HXFH009)
- West China Hospital of Sichuan University (U23A20395, 82170375, 82202310, 11902211, 2023NSFSC1339, 2023NSFSC1630, ZYGD23021, 23HXFH009)
This publication has 244 references indexed in Scilit:
- Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection PotencyAdvanced Materials, 2023
- High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical ApplicationsAdvanced Healthcare Materials, 2023
- Diagnosis and Treatment of Pulmonary Arterial HypertensionJAMA, 2022
- Enzymatically Transformable Polymersome‐Based Nanotherapeutics to Eliminate Minimal Relapsable CancerAdvanced Materials, 2021
- Exosome Biochemistry and Advanced Nanotechnology for Next‐Generation Theranostic PlatformsAdvanced Materials, 2018
- Cell Membrane Coating NanotechnologyAdvanced Materials, 2018
- Enzyme‐Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial InfarctionAdvanced Materials, 2015
- Recent Advances in Targeted, Self‐Assembling Nanoparticles to Address Vascular Damage Due to AtherosclerosisAdvanced Healthcare Materials, 2015
- Hybrid Nanoparticles for Detection and Treatment of CancerAdvanced Materials, 2012
- Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug DeliveryAdvanced Materials, 2012